Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Cord Blood Stem Cells Market by Type (Allogeneic Stem Cell, Autologous Stem Cell), By Application (Autoimmune Diseases, Immunodeficiencies, Malignancies,Caners, Solid Tumors, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Cord Blood Stem Cells Market by Type (Allogeneic Stem Cell, Autologous Stem Cell), By Application (Autoimmune Diseases, Immunodeficiencies, Malignancies,Caners, Solid Tumors, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 133885 3300 Pharma & Healthcare 377 233 Pages 4.8 (38)
                                          

Market Overview:


The global cord blood stem cells market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising incidence of chronic diseases, increasing awareness about cord blood banking, and technological advancements in the field of stem cell therapy. However, high cost associated with cord blood banking and lack of reimbursement policies are some factors that are likely to restrain the growth of this market during the forecast period. The global cord blood stem cells market can be segmented on the basis of type into allogeneic and autologous stem cells. Allogeneic stem cells are obtained from a donor other than the patient himself or herself, while autologous stem cells are obtained from the patient himself or herself. On the basis of application, this market can be divided into autoimmune diseases, immunodeficiencies, malignancies (cancers), solid tumors, and others (such as genetic disorders). Geographically speaking, this market is segmented into North America (the U.S., Canada), Latin America (Mexico & Brazil), Europe (Germany & France), Asia Pacific (China & Japan) and Middle East & Africa (South Africa).


Global Cord Blood Stem Cells Industry Outlook


Product Definition:


Cord blood stem cells are derived from the umbilical cord and placenta after a baby is born. These stem cells are used to treat various forms of cancer, blood disorders, immune system deficiencies, and metabolic diseases.


Allogeneic Stem Cell:


Allogeneic stem cells are those obtained from another individual and injected into the patient's body to fight against diseases or injuries. These cells have the ability to replace damaged or diseased tissue in the human body. The allogeneic stem cell market is currently booming due to its extensive usage in research as well as clinical settings, rising prevalence of chronic conditions, and increasing demand for transplantation procedures.


Autologous Stem Cell:


Autologous stem cells are the ones that are extracted from the patient's body and then used in regenerative medicine for treatment of various diseases. Autologous transplantation is a procedure wherein, the patient's own cells or tissues are used to treat a disease or condition instead of buying them from outside sources. These autologous stem cells have several advantages over allogenic (from another person) ones as they can be produced in bulk and possess greater healing potential.


Application Insights:


The autoimmune diseases segment dominated the global cord blood stem cells market in 2017. This can be attributed to the increasing prevalence of chronic conditions, such as diabetes, across the globe. Cord blood transplantation has been reported to be a successful treatment modality in several cases of Type 1 and Type 2 diabetes. Thus, there is a high demand for autologous stem cell therapies for various autoimmune disorders.


Cord blood also holds immense potential in regenerative medicine due to its rich sources of hematopoietic tissue-based medicines. These medicines are used for treating patients with immunodeficiency disorders or genetic abnormalities that prevent their bodies from producing adequate amounts of white blood cells or red Blood Cells (RBCs).


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to increasing R&D investments by private as well as public entities, rising adoption of advanced technologies and availability of a large patient pool. Moreover, growing number of cord blood transplants are also expected to boost the regional demand for stem cells over the forecast period.


Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing healthcare expenditure and awareness regarding stem cell therapy in emerging countries such as China & India. In addition, supportive government initiatives aimed at encouraging clinical research that include tax benefits are expected drive regional growth over next eight years.


Growth Factors:


  • Increasing incidence of chronic diseases: The increasing incidence of chronic diseases such as cancer, heart disease, and diabetes is expected to drive the demand for cord blood stem cells in the coming years.
  • Growing awareness about cord blood banking: There is a growing awareness among parents about the benefits of cord blood banking, which is expected to boost the market growth in the near future.
  • Technological advancements in stem cell therapies: The technological advancements in stem cell therapies are anticipated to create new opportunities for the growth of this market over the next few years.
  • Rising number of transplant procedures: The rising number of transplant procedures across the globe is projected to fuel demand for cord blood stem cells in coming years.

Scope Of The Report

Report Attributes

Report Details

Report Title

Cord Blood Stem Cells Market Research Report

By Type

Allogeneic Stem Cell, Autologous Stem Cell

By Application

Autoimmune Diseases, Immunodeficiencies, Malignancies,Caners, Solid Tumors, Others

By Companies

Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics Inc., Athersys Inc., Geron Corporation, Neostem Inc., CBR Systems, Inc., Cordlife, Cryo-Cell, Cryo-Save AG (A Group of Esperite), Lifecell, Stemcyte, Viacord, Smart Cells International Ltd., Cryoviva India, Cordvida, China Cord Blood Corporation

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Cord Blood Stem Cells Market Report Segments:

The global Cord Blood Stem Cells market is segmented on the basis of:

Types

Allogeneic Stem Cell, Autologous Stem Cell

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Autoimmune Diseases, Immunodeficiencies, Malignancies,Caners, Solid Tumors, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Advanced Cell Technology
  2. California Stem Cell
  3. Cytori Therapeutics
  4. Mesoblast Limited
  5. Opexa Therapeutics Inc.
  6. Athersys Inc.
  7. Geron Corporation
  8. Neostem Inc.
  9. CBR Systems, Inc.
  10. Cordlife
  11. Cryo-Cell
  12. Cryo-Save AG (A Group of Esperite)
  13. Lifecell
  14. Stemcyte
  15. Viacord
  16. Smart Cells International Ltd.
  17. Cryoviva India
  18. Cordvida
  19. China Cord Blood Corporation

Global Cord Blood Stem Cells Market Overview


Highlights of The Cord Blood Stem Cells Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Allogeneic Stem Cell
    2. Autologous Stem Cell
  1. By Application:

    1. Autoimmune Diseases
    2. Immunodeficiencies
    3. Malignancies,Caners
    4. Solid Tumors
    5. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Cord Blood Stem Cells Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Cord Blood Stem Cells Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Cord blood stem cells are a type of cell that can be collected from the umbilical cord and placenta after birth. These cells have the potential to become any type of cell in the body, including nerve cells, heart cells, and blood cells. Cord blood stem cells are currently being used to treat a variety of diseases, including leukemia, lymphoma, and other cancers.

Some of the key players operating in the cord blood stem cells market are Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics Inc., Athersys Inc., Geron Corporation, Neostem Inc., CBR Systems, Inc., Cordlife, Cryo-Cell, Cryo-Save AG (A Group of Esperite), Lifecell, Stemcyte, Viacord, Smart Cells International Ltd., Cryoviva India, Cordvida, China Cord Blood Corporation.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Cord Blood Stem Cells Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Cord Blood Stem Cells Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Cord Blood Stem Cells Market - Supply Chain
   4.5. Global Cord Blood Stem Cells Market Forecast
      4.5.1. Cord Blood Stem Cells Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Cord Blood Stem Cells Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Cord Blood Stem Cells Market Absolute $ Opportunity

5. Global Cord Blood Stem Cells Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Cord Blood Stem Cells Market Size and Volume Forecast by Type
      5.3.1. Allogeneic Stem Cell
      5.3.2. Autologous Stem Cell
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Cord Blood Stem Cells Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Cord Blood Stem Cells Market Size and Volume Forecast by Application
      6.3.1. Autoimmune Diseases
      6.3.2. Immunodeficiencies
      6.3.3. Malignancies,Caners
      6.3.4. Solid Tumors
      6.3.5. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Cord Blood Stem Cells Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Cord Blood Stem Cells Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Cord Blood Stem Cells Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Cord Blood Stem Cells Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Cord Blood Stem Cells Demand Share Forecast, 2019-2029

9. North America Cord Blood Stem Cells Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Cord Blood Stem Cells Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Cord Blood Stem Cells Market Size and Volume Forecast by Application
      9.4.1. Autoimmune Diseases
      9.4.2. Immunodeficiencies
      9.4.3. Malignancies,Caners
      9.4.4. Solid Tumors
      9.4.5. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Cord Blood Stem Cells Market Size and Volume Forecast by Type
      9.7.1. Allogeneic Stem Cell
      9.7.2. Autologous Stem Cell
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Cord Blood Stem Cells Demand Share Forecast, 2019-2029

10. Latin America Cord Blood Stem Cells Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Cord Blood Stem Cells Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Cord Blood Stem Cells Market Size and Volume Forecast by Application
      10.4.1. Autoimmune Diseases
      10.4.2. Immunodeficiencies
      10.4.3. Malignancies,Caners
      10.4.4. Solid Tumors
      10.4.5. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Cord Blood Stem Cells Market Size and Volume Forecast by Type
      10.7.1. Allogeneic Stem Cell
      10.7.2. Autologous Stem Cell
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Cord Blood Stem Cells Demand Share Forecast, 2019-2029

11. Europe Cord Blood Stem Cells Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Cord Blood Stem Cells Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Cord Blood Stem Cells Market Size and Volume Forecast by Application
      11.4.1. Autoimmune Diseases
      11.4.2. Immunodeficiencies
      11.4.3. Malignancies,Caners
      11.4.4. Solid Tumors
      11.4.5. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Cord Blood Stem Cells Market Size and Volume Forecast by Type
      11.7.1. Allogeneic Stem Cell
      11.7.2. Autologous Stem Cell
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Cord Blood Stem Cells Demand Share, 2019-2029

12. Asia Pacific Cord Blood Stem Cells Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Cord Blood Stem Cells Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Cord Blood Stem Cells Market Size and Volume Forecast by Application
      12.4.1. Autoimmune Diseases
      12.4.2. Immunodeficiencies
      12.4.3. Malignancies,Caners
      12.4.4. Solid Tumors
      12.4.5. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Cord Blood Stem Cells Market Size and Volume Forecast by Type
      12.7.1. Allogeneic Stem Cell
      12.7.2. Autologous Stem Cell
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Cord Blood Stem Cells Demand Share, 2019-2029

13. Middle East & Africa Cord Blood Stem Cells Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Cord Blood Stem Cells Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Cord Blood Stem Cells Market Size and Volume Forecast by Application
      13.4.1. Autoimmune Diseases
      13.4.2. Immunodeficiencies
      13.4.3. Malignancies,Caners
      13.4.4. Solid Tumors
      13.4.5. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Cord Blood Stem Cells Market Size and Volume Forecast by Type
      13.7.1. Allogeneic Stem Cell
      13.7.2. Autologous Stem Cell
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Cord Blood Stem Cells Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Cord Blood Stem Cells Market: Market Share Analysis
   14.2. Cord Blood Stem Cells Distributors and Customers
   14.3. Cord Blood Stem Cells Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Advanced Cell Technology
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. California Stem Cell
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Cytori Therapeutics
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Mesoblast Limited
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Opexa Therapeutics Inc.
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Athersys Inc.
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Geron Corporation
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Neostem Inc.
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. CBR Systems, Inc.
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Cordlife
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Cryo-Cell
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Cryo-Save AG (A Group of Esperite)
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Lifecell
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Stemcyte
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. Viacord
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. Smart Cells International Ltd.
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. Cryoviva India
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. Cordvida
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. China Cord Blood Corporation
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us